PS.

NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals

NHS EnglandcontractFind a Tender ↗Ref ocds-h6vhtk-0380b432014L0024active

Estimated value

—

goods

Awarded value

—

Suppliers

63

32 SME

Lots

2

63 awarded

Published

06 Apr 2023

Description

NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals<br/><br/>Offer reference number: CM/PHR/22/5675<br/><br/>CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/><br/>CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months

Scope

Reference
CM/PHR/22/5675
Commercial tool
Standalone contract
Contract dates
30 Apr 2023 to 30 Apr 2025
Main category
goods
CPV classifications
33600000
Contract locations
UK

Award criteria

Criteria the buyer will use to evaluate bids.

NameDescriptionTypeWeighting
——price—

Submission & procedure

Procedure
Open procedure

Award details· 63 awards

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

—

Award date

—

Contract start

—

Contract end

—

Awarded to
MP
Mercury Pharmaceuticals Limited
BP
Bayer Plc
SL
Sandoz Ltd
SME
PL
Pfizer Ltd
AL
Accord-UK Ltd
OP
Otsuka Pharmaceuticals UK Limited
SME
MP
Morningside Pharmaeuticals
SME
AP
Astellas Pharma Ltd
SME
IP
Ipsen
MY
Mylan
SME
FP
Ferring Pharmaceuticals Ltd
SME
DL
Drugsrus Ltd
SME
MP
medac Pharma LLP
JL
Janssen-Cilag Ltd
DL
Day Lewis Medical Ltd
TU
Teva UK Limited
PH
Pharmasure
SME
RR
Recordati Rare Diseases UK Ltd
SME
CL
Chiesi Limited
AP
Aspen Pharmacare UK Limited
GR
Gedeon Richter UK Ltd
SME
NP
Nordic Pharma
SME
NP
Novartis Pharmaceuticals UK Ltd
SY
Synchrony
SME
OU
Orifarm UK
EL
Eli Lilly and Company Ltd
CP
CST Pharma Limited
SME
RB
ROVI Biotech Ltd
SME
DP
Dexcel Pharma Ltd
GL
Gerot Lannach UK Ltd
SME
AP
Aventis Pharma ltd t/a Sanofi
TL
Tillomed Laboratories ltd
SL
Sandoz Ltd
SME
PL
Pfizer Ltd
AL
Accord-UK Ltd
MP
Morningside Pharmaeuticals
SME
WU
Wockhardt UK Limited
SME
LH
Lupin Healthcare (UK) Limited
SME
MY
Mylan
SME
NU
Neuraxpharm UK Ltd
SME
RP
Ridge Pharma
SME
FP
Ferring Pharmaceuticals Ltd
SME
DL
Drugsrus Ltd
SME
KP
Kent Pharma Ltd
SME
MP
Martindale Pharma
JL
Janssen-Cilag Ltd
DL
Day Lewis Medical Ltd
ZP
Zentiva Pharma UK Ltd
GP
Glenmark Pharmaceuticals Europe Limited
PH
Pharmasure
SME
XI
Xiromed
AP
Aspire Pharma Limited
SME
CL
Chiesi Limited
SS
Selective Supplies Ltd.
SME
NP
Napp Pharmaceuticals Ltd
GR
Gedeon Richter UK Ltd
SME
NP
Norgine Pharmaceuticals Limited
SME
QP
QDEM PHARMACEUTICALS LIMITED
CP
CST Pharma Limited
SME
MS
Merck Serono Limited
TU
Takeda UK Ltd
TP
Tetris Pharma Lts
SME
TH
Theramex HQ UK

Lots · 2 total

Divisions of the contract. Each lot can be awarded separately.

View all →
LotTitleEst. valueStatus
1CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines – Lot 1£613.9mcancelled
2CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – Lot 2£105.7mcancelled